{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.1149","meta":{"versionId":"6","lastUpdated":"2021-11-02T01:01:56.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"NCQA PHEMUR Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2021-11-02"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1149","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.464.1003.1149"}],"version":"20211102","name":"SubstanceUseDisorderLongActingMedication","title":"Substance Use Disorder Long Acting Medication","status":"active","experimental":false,"date":"2021-11-02T01:01:56-04:00","publisher":"NCQA PHEMUR","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: The purpose of this Grouping value set is to represent concepts for long acting substance use disorder medications.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable buprenorphine implant, buprenorphine injection and naltrexone injection medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients. Excludes short acting oral and sublingual medications.)","compose":{"include":[{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1143"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1144"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1147"]}]},"expansion":{"identifier":"urn:uuid:bcab4e66-a697-4212-bddd-6b1a069e989e","timestamp":"2023-12-11T02:21:18-05:00","total":6,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1655032","display":"1 ML buprenorphine 0.3 MG/ML Cartridge"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1797650","display":"buprenorphine 74.2 MG Drug Implant"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1996184","display":"0.5 ML buprenorphine 200 MG/ML Prefilled Syringe"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1996192","display":"1.5 ML buprenorphine 200 MG/ML Prefilled Syringe"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"238129","display":"1 ML buprenorphine 0.3 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"637213","display":"naltrexone 380 MG Injection"}]}}